ProStocks Logo
Unlimited Trades ₹899 Monthly
www.ProStocks.com
Contact us

Nephro Care IPO vs Visaman Global Sales IPO

Comparison between Nephro Care IPO and Visaman Global Sales IPO.

IPO Details

Nephro Care IPO is a SME Fixed Price IPO proposed to list at NSE SME while Visaman Global Sales IPO is a SME Fixed Price proposed to list at NSE SME.

 Nephro Care IPOVisaman Global Sales IPO
LogoNephro Care IPO LogoVisaman Global Sales IPO Logo
Issue CategorySMESME
Issue TypeIPOIPO
Process TypeBookbuildingFixed Price
Listing AtNSE SMENSE SME
Lead ManagersCorporate Capital Ventures Pvt.Ltd.Shreni Shares Ltd.
RegistrarBigshare Services Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Market MakerSS Corporate Securities Ltd.Shreni Shares Ltd.
DRHPDRHP DRHP
RHPRHP RHP
Final ProspectusFinal Prospectus Final Prospectus
Anchor InvestorAnchor Investor
IPO Allotment URLIPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Nephro Care IPO is up to ₹39.18 Cr whereas the issue size of the Visaman Global Sales IPO is up to ₹15.22 Cr. The final issue price of Nephro Care IPO is ₹90.00 per share and of Visaman Global Sales IPO is ₹43.00 per share.

 Nephro Care IPOVisaman Global Sales IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹85.00 per share
Issue Price (Upper)₹90.00 per share
Issue Price (Final)₹90.00 per share₹43.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)₹0.00 per share
Market Lot Size1600 shares3000 shares
Fresh Issue Size43,53,600 shares35,40,000 shares
Fresh Issue Size (Amount)up to ₹39.18 Crup to ₹15.22 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total43,53,600 shares35,40,000 shares
Issue Size Total (Amount)up to ₹39.18 Crup to ₹15.22 Cr

IPO Timetable

Nephro Care IPO opens on Jun 28, 2024, while Visaman Global Sales IPO opens on Jun 24, 2024. The closing date of Nephro Care IPO and Visaman Global Sales IPO is Jul 02, 2024, and Jun 26, 2024, respectively.

 Nephro Care IPOVisaman Global Sales IPO
Anchor Bid DateJun 27, 2024
Issue OpenJun 28, 2024Jun 24, 2024
Issue CloseJul 02, 2024Jun 26, 2024
Basis Of Allotment (Tentative)Jul 03, 2024Jun 27, 2024
Initiation of Refunds (Tentative)Jul 04, 2024Jun 28, 2024
Credit of Share (Tentative)Jul 04, 2024Jun 28, 2024
Listing date (Tentative)Jul 05, 2024Jul 01, 2024
Anchor Lockin End date 1Aug 02, 2024
Anchor Lockin End date 2Oct 01, 2024

Financials & KPIs

Nephro Care IPO P/E ratio is 55.15, as compared to Visaman Global Sales IPO P/E ratio of 38.25.

 Nephro Care IPOVisaman Global Sales IPO
Financials

Company Financials (Restated)

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets20.308.314.631.13
Total Income19.9017.103.431.83
Profit After Tax3.401.94-0.010.09
NET Worth13.922.440.500.02
Reserves and Surplus13.331.94-0.000.01
Total Borrowing2.462.540.69
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets80.0258.6439.8227.27
Total Income206.91376.05324.07136.36
Profit After Tax1.021.130.950.33
NET Worth10.959.946.605.66
Reserves and Surplus3.952.941.800.86
Total Borrowing56.9143.4613.867.10
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)85.02%100.00%
Promoter Shareholding (Post-Issue)61.39%72.98%
P/E Ratio55.1538.25
Market Cap₹148.38 Cr.₹59.39 Cr.
ROE41.579.28
ROCE36.568.02
Debt/Equity5.20
EPS₹1.63₹1.12
RoNW24.429.28

Shares Offered

In the Nephro Care IPO Retail Individual Investors (RII) are offered 14,44,800 shares while in Visaman Global Sales IPO retail investors are offered 14,44,800 shares. Qualified Institutional Buyers (QIB) are offered 8,25,600 shares in Nephro Care IPO and 0 shares in Visaman Global Sales IPO.

 Nephro Care IPOVisaman Global Sales IPO
Anchor Investor Reservation12,38,400 shares0 shares
Market Maker Reservation2,30,400 shares1,92,000 shares
QIB8,25,600 shares0 shares
NII6,19,200 shares17,70,000 shares
RII14,44,800 shares17,70,000 shares
Employee2,25,600 shares0 shares
Total43,53,600 shares35,40,000 shares

Bids Received (Subscription)

Nephro Care IPO subscribed 512.17x in total, whereas Visaman Global Sales IPO subscribed 39.83x.

 Nephro Care IPOVisaman Global Sales IPO
QIB (times)245.14x
NII (times)1,787.19x28.12x
RII (times)634.12x51.54x
Employee (times)0.00x
Total (times)512.17x39.83x

Compare with others

Nephro Care IPOVisaman Global Sales IPO
Sahaj Solar IPOGanesh Green Bharat IPO
Aelea Commodities IPOEffwa Infra IPO
Ganesh Green Bharat IPOAmbey Laboratories IPO
Effwa Infra IPONephro Care IPO
Ambey Laboratories IPODiensten Tech IPO
Diensten Tech IPOMason Infratech IPO
Visaman Global Sales IPOPetro Carbon IPO
Mason Infratech IPOSylvan Plyboard IPO
Petro Carbon IPOShivalic Power Control IPO
Sylvan Plyboard IPODivine Power Energy IPO

Compare:

Nephro Care IPO Vs Visaman Global Sales IPO